Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Journal of Viral Hepatitis|February 26, 2020
Randomized clinical trials towards a single-visit cure for chronic hepatitis C: Oral GSK2878175 and injectable RG-101 in chronic hepatitis C patients and long-acting injectable GSK2878175 in healthy participantsYanli Deng, Fiona Campbell, Kelong Han, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|February 19, 2008
Effect of omeprazole on the plasma concentrations of indinavir when administered alone and in combination with ritonavirHiba L Tappouni, John C Rublein, Brian J Donovan, et al.
Advances in Therapy|November 9, 2022
Characteristics, Treatment Patterns, and Clinical Outcomes of Chronic Hepatitis B Across 3 Continents: Retrospective Database StudyIain A Gillespie, K Arnold Chan, Yunhao Liu, et al.
Gastroenterology|December 17, 2009
Farglitazar lacks antifibrotic activity in patients with chronic hepatitis C infectionJohn McHutchison, Zachary Goodman, Keyur Patel, et al.
Clinical Pharmacology in Drug Development|March 13, 2019
A Randomized, Double-Blind, Placebo-Controlled, First-Time-in-Human Study to Assess the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of GSK3389404 in Healthy SubjectsKelong Han, Jennifer Cremer, Robert Elston, et al.
Nature Medicine|October 13, 2021
Safety, tolerability and antiviral activity of the antisense oligonucleotide bepirovirsen in patients with chronic hepatitis B: a phase 2 randomized controlled trialMan-Fung Yuen, Jeong Heo, Jeong-Won Jang, et al.
JHEP Reports : Innovation in Hepatology|June 9, 2026
Bepirovirsen induces innate immune activation in the liver potentially through TLR8 signalingMegan E Ermler, Jared L Delahaye, William Jordan, et al.
Lancet (London, England)|August 2, 2015
Eltrombopag for children with chronic immune thrombocytopenia (PETIT2): a randomised, multicentre, placebo-controlled trialJohn D Grainger, Franco Locatelli, Thirachit Chotsampancharoen, et al.
The Lancet. Haematology|December 22, 2015
Eltrombopag for the treatment of children with persistent and chronic immune thrombocytopenia (PETIT): a randomised, multicentre, placebo-controlled studyJames B Bussel, Purificación Garcia de Miguel, Jenny M Despotovic, et al.
Gastroenterology|October 16, 2013
Eltrombopag increases platelet numbers in thrombocytopenic patients with HCV infection and cirrhosis, allowing for effective antiviral therapyNezam H Afdhal, Geoffrey M Dusheiko, Edoardo G Giannini, et al.
Pageof 5